P3.02a-001 Response and Plasma Genotyping from Phase I/II Trial of Ensartinib (X-396) in Patients (pts) with ALK+ NSCLCLeora Horn,Heather Wakelee,Karen Reckamp,George Blumenschein,Jeffrey Infante,Corey Carter,Saiama Waqar,Joel Neal,Jon Gockerman,Kimberly Harrow,Gary Dukart,Chris Liang,James Gibbons,Jennifer Hernandez,Tera Newman-Eerkes,Lee Lim,Christine LovlyJournal of Thoracic Oncology（2017）引用 6|浏览30AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
